• Trending Topics:    
  • 2024 Election
  • Joe Biden
  • Donald Trump
  • Congress
  • Faith
  • Sports
  • Immigration
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Headlines
No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Headlines
No Result
View All Result
IJR
No Result
View All Result
Home IJR

WH Testing Czar Says COVID-19 Vaccines ‘Will Be Effective’ Against New Strain of the Virus

Madison Summers by Madison Summers
December 21, 2020 at 1:23 pm
in IJR
235 17
0
WH Testing Czar Says COVID-19 Vaccines ‘Will Be Effective’ Against New Strain of the Virus
491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

White House coronavirus testing czar Adm. Brett Giroir is seeking to encourage people that the COVID-19 vaccine candidates will be effective against other variants of COVID-19.

Giroir, the assistant secretary for Health, sought to tamp down fears over the new COVID-19 variant reported in the U.K. during Monday’s CNN “New Day” interview.

“We have every reason to believe that the vaccine will be effective against any variant that we’ve seen, including the new variant in the U.K.,” he said.

Giroir also said, “It is not any more lethal or any more dangerous than the normal coronavirus, no evidence to suggest that, no reason to believe it.” He noted that it has not been proven the variant is more transmissible.

U.K. Prime Minister Boris Johnson announced over the weekend that there will be stricter coronavirus restrictions implemented and that there was a new variant of the coronavirus identified. It appears to be accelerating the spread of the virus, according to England’s chief medical officer, Chris Whitty.

Johnson, however, said, “There’s no evidence to suggest it is more lethal or causes more severe illness.”

It is regularly occurring that viruses mutate.

Watch the video below:

Adm. Brett Giroir, Asst Sec for Health, talks about the new COVID variant in the UK: "It is not any more lethal or any more dangerous than the normal coronavirus, no evidence to suggest that, no reason to believe it."

Also no evidence that it will evade the vaccines we have. pic.twitter.com/uQRNnJ6P5f

— The Recount (@therecount) December 21, 2020

Countries ban travel from UK after new variant of COVID-19 detected. @JamesAALongman reports. https://t.co/Ts06Y3qi7O pic.twitter.com/f9K1wjnTiu

— Good Morning America (@GMA) December 21, 2020

Dr. Scott Gottlieb, a former U.S. Food and Drug Administration commissioner, also spoke about the announcement of the new variant found in the U.K.

See Gottlieb’s comments below:

"This is a mutation," says @ScottGottliebMD on new strain of COVID-19 discovered in the U.K. "We now think this is more transmissible– it doesn't seem to have mutated the surface proteins of the virus in a way that would slip past the vaccines or prior immunity." pic.twitter.com/zuO9b4H9eM

— CNBC (@CNBC) December 21, 2020

He told CNBC on Monday, “We now think this is more transmissible. It doesn’t seem to have mutated the surface proteins of the virus in a way that would slip past the vaccines or prior immunity.”

Tags: Brett GiroirCoronavirus OutbreakScott Gottlieb
[firefly_poll]

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Headlines

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Thanks for reading IJR

Create your free account or log in to continue reading

Please enter a valid email
Forgot password?

By providing your information, you are entitled to Independent Journal Review`s email news updates free of charge. You also agree to our Privacy Policy and newsletter email usage